Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03724448
Other study ID # PHYTéS
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date June 30, 2018
Est. completion date September 1, 2018

Study information

Verified date March 2023
Source Hôpital Universitaire Sahloul
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Psycho-traumatic disorders are a disabling condition whose epidemiological data vary according to the country but also the populations studied and the measuring instruments used. The estimated prevalence of posttraumatic stress disorder (PTSD) appeared to be increasing in recent years, and this appears to be due, among other things, to the improvement of the standardized evaluation procedure. The survey "Mental Health in General Population", conducted in metropolitan France between 1999 and 2003 on more than 36,000 people estimated its instantaneous prevalence (last month) of a full PTSD was 0.7% in the SMPG overall sample, with almost equal frequency between men (45%) and women (55%). This figure is close to that reported in a European population for the ESEMeD study. A very significant psychiatric comorbidity was found in subjects with PTSD, particularly with mood disorders, other anxiety disorders and addictive behaviors. The link with the suicidal risk was clearly established, which is the gravity of this pathology. The most important publications are made by American teams who have identified and evaluated the treatment of this pathology among veterans of the various wars led by the country.


Description:

Psycho-traumatic disorders are a disabling condition whose epidemiological data vary according to the country but also the populations studied and the measuring instruments used. The estimated prevalence of posttraumatic stress disorder (PTSD) appeared to be increasing in recent years, and this appears to be due, among other things, to the improvement of the standardized evaluation procedure. The survey "Mental Health in General Population", conducted in metropolitan France between 1999 and 2003 on more than 36,000 people estimated its instantaneous prevalence (last month) of a full PTSD was 0.7% in the SMPG overall sample, with almost equal frequency between men (45%) and women (55%). This figure is close to that reported in a European population for the ESEMeD study. A very significant psychiatric comorbidity was found in subjects with PTSD, particularly with mood disorders, other anxiety disorders and addictive behaviors. The link with the suicidal risk was clearly established, which is the gravity of this pathology. The most important publications are made by American teams who have identified and evaluated the treatment of this pathology among veterans of the various wars led by the country. Barrois defines traumatic neurosis as "a group of psychological disorders that arise after a longer or shorter latency, following a very intense emotional shock". Post-traumatic stress disorder is defined by the ICD-10 classification as a "delayed or prolonged" response to a stressful situation or event (short or long-term) that would provoke distress symptoms in anyone . According to the American classification of the DSM-V, the diagnosis of PTSD is strictly established according to different criteria. Exposure to a traumatic event ("the person has been exposed, witnessed or confronted with an event or events that have involved death or death, or serious injury or threat to their physical integrity or 'others'), and reacting to it with a feeling of intense fear, helplessness or horror (criterion A). The event is constantly relived, manifested by at least one symptom of the repetition syndrome (criterion B) that can be repetitive and invasive memories of the event (including images, thoughts, perceptions), repetitive and painful dreams of the event, the impression or sudden acts "as if" the traumatic event recurred, an intense psychological distress when exposed to internal or external stimuli resembling an aspect of the trauma, a physiological reactivity during exposure to internal or external stimuli resembling or symbolizing an aspect of the trauma. Criterion C requires persistent avoidance of stimuli associated with trauma and blunting of general responsiveness (not present before trauma). Criterion D refers to the impairment of cognition and mood associated with one or more traumatic events manifested by at least two symptoms, including dissociative amnesia, persistent and exaggerated negative self-perceptions of others, and world, a clear reduction of interest in important activities, a feeling of detachment and a persistent inability to feel positive emotions. There are also symptoms of neurovegetative activation, with at least two symptoms (criterion E) among sleep difficulties, irritability or anger, difficulty concentrating, hyper vigilance, startled reactions exaggerated. Criterion F concerns the duration of symptoms B, C and D which must exceed one month. The problem results in clinically significant distress or dysfunction at the social, occupational or other important operational level (criterion G). Criterion H eliminates that these symptoms are not due to the consumption of a substance (drug or alcohol) or another condition. Despite this awareness of the functional impact of these psycho traumatic disorders, this pathology has remained under-identified both by health professionals and the general public and subsequently insufficiently treated, particularly in Tunisia. Several therapeutic protocols are proposed. The share of antidepressant treatments (yet first-line treatment in all international guidelines) is only 30% and the remaining 70% includes anxiolytics, hypnotics and herbal medicine. Several meta-analyzes have evaluated the efficacy of different families of antidepressants, but scientific research remains very poor in the field of herbal medicine.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date September 1, 2018
Est. primary completion date September 1, 2018
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Any patient who has been exposed to a traumatic event that could cause an acute PTSD (accident or aggression that causes intense fear, helplessness or horror) - a PDI (Peri-traumatic Distress Inventory) score and / or PDEQ (Traumatic Traumatic Dissociation Experience Questionnaire - Evaluative Form) - and / or (Appendix 1, 2 and 3) calculated between J1 and J3 and estimated moderate or high with a score> 15. Exclusion Criteria: - Any serious traumatized patient who needed treatment in intensive care. - Any patient with psychiatric illness or psychotropic medication prior to randomization. - Non-cooperating patient (unable to answer the assessment test). - Non consenting patient.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
aleozen
treatment with herbal medicine
Placebo Oral Tablet
No aleozen treatment

Locations

Country Name City State
Tunisia HU Sahloul, sousse, Tunisia Sousse Itinéraire Ceinture Cité Sahloul

Sponsors (1)

Lead Sponsor Collaborator
Hôpital Universitaire Sahloul

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary 50% diminution or stabilization of CAPS score after 3 and 6 months 50% diminution or stabilization of CAPS score after 3 and 6 months of patient's inclusion
See also
  Status Clinical Trial Phase
Recruiting NCT03946319 - Personalized, Transdiagnostic Approach to Preventative Mental Health N/A
Terminated NCT00593931 - Development Of New Techniques For Functional Magnetic Resonance Imaging Of The Brain N/A
Recruiting NCT03525054 - Semantic and Syntactic Computerized Analysis of Free Speech
Recruiting NCT06315114 - A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders N/A
Completed NCT03366896 - Validation Study of the Malay Version of 3D-CAM N/A
Recruiting NCT06213220 - Wearable Devices System Diagnoses Mood Disorder in Children and Adolescents
Not yet recruiting NCT01799668 - Therapists' Preferences for Client Characteristics and Their Influence on the Therapeutic Alliance N/A
Completed NCT04467658 - Neurophysiological Marker of ADHD in Children
Completed NCT00134615 - Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting N/A
Completed NCT05294094 - Learning Diagnostic Skills Online (German: Diagnostik Skills Online Lernen) N/A